國光生（4142）公布 2026年4月營收 0.23億元，年增 474.4%
NQ 評分
0/100
N1 內容完整性
0
AI 摘要（NQ 加工版）
Adimmune Corp. (國光生) reported April 2026 revenue of NT$23 million, a massive 474.4% year-on-year increase, indicating exceptional growth in the biotechnology and medical industry.